17th Apr 2007 16:57
Skyepharma PLC17 April 2007 SkyePharma PLC ("the Company") Notification of Major Interest in Shares In accordance with paragraph 5.1.2 of the Disclosure and Transparency Rules, theCompany has received a notification dated 13 April 2007 from Aviva plc and itssubsidiaries ("Aviva") stating that as at 11 April 2007, it held a notifiableinterest of 83,999,653 shares in SkyePharma PLC, which represents 10.31% of thevoting rights in the Company. 9.62% are held directly and 0.69% are heldindirectly. Direct holdings: BNY Norwich Union Nominees Limited 19,270,661 shares Chase GA Group Nominees Limited 41,674,191 shares Chase Nominees Limited 1,381,373 shares CUIM Nominee Limited 15,859,401 shares Vidacos Nominees Limited 222,791 shares 78,408,417 shares (9.62%) Indirect holdings: Chase Nominees Limited 1,361,734 shares CUIM Nominee Limited 859,130 shares Vidacos Nominees Limited 3,370,372 shares 5,591,236 Shares (0.69%) Prior to the triggering transaction, Aviva held 43,183,326 Ordinary Shares andnotifies the Company that the percentage thresholds that have been crossed are6% to 10% (inclusive) at the combined interest level. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.LAviva